Eris M. J. Biopharm Private Limited - Company Profile

It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2002.
2002 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Eris M. J. Biopharm Private Limited

Eris M. J. Biopharm Private Limited, a active private limited company, was established on 18 September 2002 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397GJ2002PTC112851. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.37 Cr.

Formerly known as Kinedex Healthcare Private Limited. It upholds a compliant status. Employing 202 professional, Its leadership includes Amol Jashvant Shah (Director), Krishnakumar Vaidyanathan (Director), Amit Indubhushan Bakshi (Director). Past directors included Sameer Ashok Paigankar, Amol Jashvant Shah, Anil Kumar Sharma. It holds no open charges and ₹3.71 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 201-204, 2Nd Floor, Shivarth Ambit, Plot No. 142/2 Ramdas Road, Off Sbr, Nr.Swati Bungalows, , Bodakdev, Ahmedabad, Gujarat, 380054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397GJ2002PTC112851

  • Registration Number

    112851

  • Incorporation Date

    18 September 2002

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹1.37 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 1.37 Cr
  • Company Age 23 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 3.71 Cr
  • Revenue Growth **** 167.06%
  • Profit Growth **** 43.00%
  • Ebitda **** 60.32%
  • Net Worth -64.92%
  • Total Assets **** 32.07%
Company report

Eris M. J. Biopharm Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eris M. J. Biopharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Eris M. J. Biopharm Private Limited?
Current Directors
Name Designation Appointment Date Status
Amol Jashvant Shah Director 12 Jan 2022 Current
Krishnakumar Vaidyanathan Director 17 Dec 2021 Current
Amit Indubhushan Bakshi Director 12 Jan 2022 Current
Akshay Amol Shah Director 12 Jan 2022 Current
Kaushal Kamlesh Shah Director 12 Dec 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Nov 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 23 Nov 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 12 Jan 2022 Past
Pramod Abcsdd Director 01 Jun 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eris M. J. Biopharm.

Eris M. J. Biopharm Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 167.06% increase. The company also saw a substantial improvement in profitability, with a 43% increase in profit. The company's net worth observed a substantial decline by a decrease of 64.92%.

Eris M. J. Biopharm revenue growth over time
Eris M. J. Biopharm profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 167.06%
*******
*******
*******
*******
Revenue from Operations
*******
 166.06%
*******
*******
*******
*******
Total Assets
*******
 32.07%
*******
*******
*******
*******
Profit or Loss
*******
 43.00%
*******
*******
*******
*******
Net Worth
*******
 -64.92%
*******
*******
*******
*******
EBITDA
*******
 60.32%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eris M. J. Biopharm?

In 2024, Eris M. J. Biopharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹37,093,292.00

Charges Breakdown by Lending Institutions
  • Ing Vysya Bank Limited : 1.75 Cr
  • Hdfc Bank Limited : 1.25 Cr
  • Others : 0.71 Cr
Latest Charge Details
Date Lender Amount Status
31 Jul 2016 Others ₹2.59 M Satisfied
05 Feb 2016 Others ₹4.50 M Satisfied
21 Mar 2013 Ing Vysya Bank Limited ₹1.75 Cr Satisfied
16 Jan 2006 Hdfc Bank Limited ₹1.25 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Eris M. J. Biopharm?

Eris M. J. Biopharm has a workforce of 202 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eris M. J. Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris M. J. Biopharm's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eris M. J. Biopharm
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Eris M. J. Biopharm Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Eris M. J. Biopharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    The activity A charge registered on 21 Mar 2013 via Charge ID 10426206 with Ing Vysya Bank Limited was fully satisfied on 11 May 2022. was completed.

  • Director Appointment

    Amol Jashvant Shah was appointed as a Director was appointed as a Director on 12 Jan 2022 & has been associated with this company since 4 years 1 month . was recorded as a recent event.

  • Director Appointment

    Amit Indubhushan Bakshi was appointed as a Director was appointed as a Director on 12 Jan 2022 & has been associated with this company since 4 years 1 month . was recorded as a recent event.

  • Director Appointment

    The activity Akshay Amol Shah was appointed as a Director was appointed as a Director on 12 Jan 2022 & has been associated with this company since 4 years 1 month . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eris M. J. Biopharm Private Limited?

The CIN of Eris M. J. Biopharm Private Limited is U51397GJ2002PTC112851.

Where is Eris M. J. Biopharm Private Limited headquartered?

Eris M. J. Biopharm Private Limited is headquartered at 201-204, 2Nd Floor, Shivarth Ambit, Plot No. 142/2 Ramdas Road, Off Sbr, Nr.Swati Bungalows, , Bodakdev, Ahmedabad, Gujarat, 380054.

When was Eris M. J. Biopharm Private Limited incorporated?

Eris M. J. Biopharm Private Limited was incorporated on 18 September 2002.

Who are the current directors of Eris M. J. Biopharm Private Limited?

The current directors of Eris M. J. Biopharm Private Limited are

What is the primary industry of Eris M. J. Biopharm Private Limited?

The primary industry of Eris M. J. Biopharm Private Limited is Trade.

Is Eris M. J. Biopharm Private Limited a listed company?

Eris M. J. Biopharm Private Limited is unlisted.

What is the capital structure of Eris M. J. Biopharm Private Limited?

The authorized capital of Eris M. J. Biopharm Private Limited is ₹3.00 Cr, and the paid-up capital is ₹1.37 Cr.

What is the compliance status of Eris M. J. Biopharm Private Limited?

The compliance status of Eris M. J. Biopharm Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available